pimonidazole has been researched along with Adenocarcinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humm, JL; Li, GC; Li, XF; Ling, CC; Russell, J; Sun, X; Urano, M; Xing, L | 1 |
| Cho, H; Koutcher, JA; Li, XF; Ling, CC; Lupu, ME; Russell, J; Yang, KM | 1 |
| An, H; Engenhart-Cabillic, R; Eul, BG; Fokas, E; Hänze, J; Heverhagen, JT; Kamlah, F; Keil, B; Lang, N; Rose, F | 1 |
| Bennewith, KL; Durand, RE | 1 |
| Begg, AC; De Schutter, H; Debucquoy, A; Ectors, N; Geboes, K; Goethals, L; Haustermans, KM; McBride, WH; Penninckx, F; Perneel, C | 1 |
| Begg, AC; Geboes, K; Haustermans, K; Hofland, I; Raleigh, J; Van de Pavert, L; Varia, M | 1 |
| Guichard, ME; Lespinasse, F; Taghian, A | 1 |
| Bleehen, NM; Newman, HF; Smithen, CE; Ward, R; Workman, P | 1 |
| George, KC; Pelzer, T; Streffer, C | 1 |
| Luscher, G; Streffer, C; Tamulevicius, P | 1 |
| Bleehen, NM; Newman, HF; Workman, P | 1 |
11 other study(ies) available for pimonidazole and Adenocarcinoma
| Article | Year |
|---|---|
Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Cell Hypoxia; Colorectal Neoplasms; Etanidazole; Female; Hydrocarbons, Fluorinated; Hyperthermia, Induced; Immunohistochemistry; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2008 |
Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.
Topics: Adenocarcinoma; Animals; Atrasentan; Colonic Neoplasms; Combined Modality Therapy; Etanidazole; Gadolinium DTPA; HT29 Cells; Humans; Hydrocarbons, Fluorinated; Hypoxia; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Nitroimidazoles; Perfusion; Pyrrolidines; Radiation-Sensitizing Agents; Radiotherapy; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzimidazoles; Biomarkers; Caspase 3; Cell Hypoxia; Contrast Media; Gadolinium; Glucose Transporter Type 1; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Time Factors; Transplantation, Heterologous | 2010 |
Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Female; Flow Cytometry; Humans; Mice; Mice, SCID; Nitroimidazoles; Oxygen; Partial Pressure; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2004 |
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Carbonic Anhydrases; Cell Hypoxia; Colonic Neoplasms; ErbB Receptors; Female; Humans; Idoxuridine; Male; Microcirculation; Middle Aged; Nitroimidazoles; Observer Variation; Rectal Neoplasms; Vascular Endothelial Growth Factor A | 2006 |
Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.
Topics: Adenocarcinoma; Blood Vessels; Carcinoma, Squamous Cell; Cell Hypoxia; Diffusion; Esophageal Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Nitroimidazoles; Observer Variation; Radiation-Sensitizing Agents; Rectal Neoplasms; Reproducibility of Results; Uterine Cervical Neoplasms | 2000 |
Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Topics: Adenocarcinoma; Animals; Cell Survival; Drug Synergism; Etanidazole; Female; Humans; Melanoma; Mice; Mice, Nude; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rectal Neoplasms | 1991 |
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Radiation-Sensitizing Agents; Stereoisomerism | 1991 |
Combined effects of X rays, Ro 03-8799, and hyperthermia on growth, necrosis, and cell proliferation in a mouse tumor.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1989 |
Effects on intermediary metabolism in mouse tissues by Ro-03-8799.
Topics: Adenocarcinoma; Animals; Body Temperature; Brain; Glucose; Glucose-6-Phosphatase; Ketone Bodies; Lipid Metabolism; Liver; Liver Glycogen; Male; Mice; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1987 |
A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
Topics: Adenocarcinoma; Drug Combinations; Drug Evaluation; Etanidazole; Humans; Melanoma; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |